遺傳檢測與諮詢的倫理議題與執業準則--罹病傾向之遺傳檢測：以BRCA檢驗為例_

:::

詳目顯示

第 1 筆 / 總合 1 筆

/1頁

來源文獻資料
引文資料

題名：	遺傳檢測與諮詢的倫理議題與執業準則--罹病傾向之遺傳檢測：以BRCA檢驗為例
書刊名：	醫學教育
作者：	蔡甫昌／朱怡康／黃天祥
作者(外文)：	Tsai, Daniel Fu-Chang／Chu, I-Kang／Huang, Tien-Shang
出版日期：	2007
卷期：	11:1
頁次：	頁69-88
主題關鍵詞：	遺傳檢測；遺傳諮詢；倫理準則；Genetic testing；Genetic counseling；BRCA；Ethics guideline
原始連結：	連回原系統網址
相關次數：	被引用次數:期刊(2) 博士論文(1) 專書(0) 專書論文(0) 排除自我引用:2 共同引用:0 點閱:51

期刊論文
1.	Feuer, E. J.、Wun, L. M.、Boring, C. C.(1993)。The lifetime risk of developing breast cancer。J Natl Cancer Inst，85，892-897。
2.	Robson, M. E.(2002)。Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer。Cancer Control，9，457-465。
3.	Markman, M.(2004)。Genetic discrimination arising from cancer risk assessments: a societal dilemma。Cleve Clin J Med，71，12-18。
4.	蘇怡寧(20020900)。乳癌之BRCA1／BRCA2之基因分析。臺灣醫學，6(5)，706-713。延伸查詢
5.	Schrag, D.、Kuntz, K. M.、Garber, J.(2000)。Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 and BRCA2 mutations。J Am Med Assoc，283，617-624。
6.	Burke, W.、Daly, M.、Garber, J.(1997)。Recommendations for follow-up care of individuals with an inherited predisposition to cancer, II: BRCA1 and BRCA2 cancer genetics studies consortium。J Am Med Assoc，277，997-1003。
7.	Early Breast Cancer Trialists' Collaborative Group(1998)。Tamoxifen for early breast cancer: an overview of the randomised trial。Lancet，351，1451-1467。
8.	Fisher, B.、Costantino, J. P.、Wickerham, D. L.(1998)。Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-l study。J Natl Cancer Inst，90，1371-1388。
9.	(1987)。The cancer and steroid hormone study of the centers for disease control and the National Institute of Child and Human Development: the reduction in risk of ovarian cancer associated with oral contraceptive use。N Engl J Med，316，650-655。
10.	NIH consensus conference, Ovarian cancer(1995)。Screening, treatment and follow-up: NIH consensus development panel on ovarian cancer。J Am Med Assoc，273，491-497。
11.	Lerman, C.、Narod, S.、Schulman, K.(1996)。BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes。J Am Med Assoc，275，1885-1892。
12.	Meijers-Heijboer, H.、van Geel, B.、van Putten, W. L. J.(2001)。Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation。N Engl J Med，345，159-164。
13.	Hartmann, L. C.、Schaid, D.、Sellers, T.(2000)。Bilateral prophylactic mastectomy (PM) in BRCA1/2 mutations carriers。Proc Am Assoc Cane Res，41，222-223。
14.	Ursin, G.、Li, C.、Pike, M. C.(2000)。Should women with a family history of breast cancer avoid use of oral contraceptives?。Epidemiology，11，615-616。
15.	Weber, B. L.、Punzalan, C.、Eisen, A.(2000)。Ovarian cancer risk reduction after bilateral prophylactic oophorectomy (BPO) in BRCA1 and BRCA2 mutation carriers。Am J Hum Genet，67(Suppl. 2)。
16.	American Society of Clinical Oncology(2003)。American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility。J Clin Oncol，21，2397-2406。
17.	de Wert, G.(1996)。Ethics of predictive DNA-testing for hereditary breast and ovarian cancer。Obstet Gynecol，87，306-309。
18.	McKinnon, W. C.、Baty, B. J.、Bennett, R. L.(1997)。Predisposition genetic testing for late-onset disorders in adults: a position paper of the National Society of Genetic Counselors。J Am Med Assoc，278，1217-1220。
19.	The American Society of Human Genetics(1998)。Professional disclosure of familial genetic information。Am J Hum Genet，62，474-483。
20.	The American College of Medical Genetics、The American Society of Human Genetics(1995)。ASHG/ACMG Report: Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents。Am. J. Hum. Genet.，57(5)，1233-1241。
21.	European Society of Human Genetics(2003)。Provision of genetic services in Europe: current practices and issues。European Journal of Human Genetics，11，900-902。
22.	Cobben, J. M.、Bröcker-Vriends, A. H.、Leschot, N. J.(2002)。Prenatal diagnosis for hereditary predisposition to mammary and ovarian carcinoma-defining a position。Ned Tijdschr Geneeskd，146，1461-1465。
23.	European Society of Human Genetics(2000)。Genetic Information and Testing in Insurance and Employment: Technical, Social and Ethical Issues。European journal of human genetics，11(12)，909-910。

研究報告
1.	Advisory Committee on Genetic Testing(1998)。Report on Genetic Testing for Late Onset Disorders。London：Health Department of United Kingdom。
2.	行政院衛生署國民健康局。衛生署癌症登記年報。延伸查詢
3.	Council on Scientific Affairs(1999)。Mammographic Screening for Asymptomatic Women: Report。Chicago, Illinois：American Medical Association。
4.	Wertz, D. C.、Fletcher, J. C.、Berg, K.(2003)。Review of Ethical Issues in Medical Genetics: Report of Consultants to WHO。Geneva：World Health Organization。
5.	Clinical Genetics Society(1994)。The Genetic Testing of Children: Report of a Working Party of the Clinical Genetics Society。
6.	Advisory Committee on Genetic Testing(2000)。Prenatal Genetic Testing: Report for Consultation。

圖書
1.	de Wert, G.、ter Meulen, R.、Mordacci, R.(2003)。Ethics and Genetics: A Workbook for Practitioners and Students。NY：Berghahn Books。
2.	The President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Biobehavioral Research(1998)。Screening and Counseling for Genetic Conditions: The Ethical, Social, and Legal Implications of Genetics Screening, Counseling and Education Programs。Washington, DC：US Government Publishing Office。
3.	Institute of Medicine Committee on Assessing Genetic Risks(1994)。Assessing Genetic Risks: Implications for Health and Social Policy。Washington, DC：National Academy Press。
4.	World Health Organization(1997)。Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Service。Geneva：World Health Organization。

其他
1.	Ethical Issues in Genetic Testing for BRCA1 and BRCA2，http://www.ama-assn.org/cmeselec/ethics。
2.	Ethical Issues in Genetic Testing for BRCA1 and BRCA2. Post-Test Confidentiality，http://www.ama-assn.org/cmeselec/ethics/60-testresults/07.htm。
3.	Association of British Insurers(1999)。Genetic Testing Code of Practice。
4.	The America College of Medical Genetics, the New York State Department of Health(1999)。Genetic Susceptibility to Breast and Ovarian Cancer: Assessment, Counseling and Testing Guidelines，http://www.health.state.ny.us/nysdoh/cancer/obcancer/pp24-27.htm。
5.	American Cancer Society(1997)。Recommendations for Early Breast Cancer Detection。
6.	Human Genetics Society of Australasia(1999)。Guidelines for the Practice of Genetic Counseling。
7.	British Medical Association(1991)。Confidentiality and Disclosure of Health Information: Examples of Disclosure in the Public Interest，http://www.bma.org.uk/ap.nsf/Content/Confidentialitydisclosure-examplespublic。
8.	Ethical Issues in Genetic Testing for BRCA1 and BRCA2. Genetic Discrimination，http://www.ama-assn.org/cmeselec/ethics/40_nondir/10.htm。

圖書論文
1.	The International Federation of Gynecology and Obstetrics(2003)。Ethical issues concerning prenatal diagnosis of disease in the conceptus, 1991。Recommendations on Ethical Issues in Obstetrics and Gynecology by the FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health。London：FIGO。
2.	The International Federation of Gynecology and Obstetrics(2003)。Ethical aspects of termination of pregnancy following prenatal diagnosis, 1991。Recommendations on Ethical Issues in Obstetrics and Gynecology by the FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health。London：FIGO。

推文
推薦
引用網址
引用嵌入語法
轉寄

top

:::

相關期刊
相關論文
相關專書
相關著作
熱門點閱

1.	遺傳疾病對護理的衝擊及挑戰
2.	遺傳疾病病患隱私與親屬利益衝突之倫理法制探討

1.	佛教經典視角的性別哲學研究

無相關書籍

無相關著作

無相關點閱

QR Code

臺灣人文及社會科學引文索引資料庫系統

詳目顯示

臺灣人文及社會科學引文索引資料庫